Evaluation Of A Novel Breast Compression Paddle For Wire Localization In Mammography
NCT00724516 is an interventional trial sponsored by University of Michigan. As of 21 Nov 2026, it is completed. It studies Biopsy, Needle and Mammography. The registry lists an enrollment of 10 participants at 1 site in 1 country. The registry lists a start date of 30 Jun 2007 and a primary completion date of 31 Dec 2009.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT00724516 |
| Status | Completed |
| Study type | Interventional trial |
| Lead sponsor | University of Michigan |
| Enrollment | 10 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Biopsy, Needle and Mammography |
| Start | 30 Jun 2007 |
| Primary completion | 31 Dec 2009 |
| Study completion | 31 Dec 2010 |
| Last update posted | 6 Jul 2017 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Caroline Blane, M.D.
University of Michigan Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Michigan Health System
Ann Arbor
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT00724516
Each answer restates registry values shown on this page.
What is NCT00724516?
NCT00724516 is an interventional trial sponsored by University of Michigan. It studies Biopsy, Needle and Mammography.
Who leads NCT00724516?
The registry names Caroline Blane, M.D. (principal investigator, University of Michigan Hospital) as the overall official.
Where does NCT00724516 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When did NCT00724516 end?
The registry lists a primary completion date of 31 Dec 2009 and a study completion date of 31 Dec 2010. The sponsor last updated the record on 6 Jul 2017.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.